Charles River Laboratories
Kelly Palumbo, CPA has extensive work experience in various financial roles. Kelly is currently the Corporate Vice President, Finance, and Corporate Controller at Charles River Laboratories since July 2023. Prior to that, they had a long tenure at Johnson & Johnson, where they held significant positions such as Vice President Finance, Global Transformation and Talent Strategies, Senior Finance Director, U.S. Beauty, Finance Director, Pharm R&D, and Finance Director, Mergers & Acquisitions. Kelly also worked as a Plant Controller and Finance Manager at J&J. Before joining Johnson & Johnson, Kelly worked as a Consultant at Conley Morgan and as a Senior Associate at PwC. Kelly started their career as an intern at PricewaterhouseCoopers. Kelly's expertise lies in finance, strategic planning, workforce strategy, mergers & acquisitions, and pharmaceutical and biologics manufacturing.
Kelly Palumbo, CPA, earned a Bachelor's degree in Accounting from Penn State University, where they attended from 1992 to 1996. In May 1997, Kelly obtained the CPA certification, although the institution from which they received it is unspecified. Kelly later pursued further education and obtained a Master of Business Administration (MBA) from Villanova University, attending from 2003 to 2007. No specific field of study is provided for their MBA degree.
This person is not in any teams
This person is not in any offices
Charles River Laboratories
15 followers
Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.